Inhibition of PTPN21 has antitumor effects in glioma by restraining the EGFR/PI3K/AKT pathway
- 27 July 2022
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 451, 116180
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Protein tyrosine phosphatases in health and diseaseThe FEBS Journal, 2012
- Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor responseProceedings of the National Academy of Sciences, 2012
- Temozolomide: Mechanisms of Action, Repair and ResistanceCurrent Molecular Pharmacology, 2012
- PTPD1 Supports Receptor Stability and Mitogenic Signaling in Bladder Cancer CellsJournal of Biological Chemistry, 2010
- The Pathobiology of Glioma TumorsAnnual Review of Pathology: Mechanisms of Disease, 2010
- Oncogenic EGFR Signaling Networks in GliomaScience Signaling, 2009
- Protein tyrosine phosphatases: dual‐specificity phosphatases in health and diseaseThe FEBS Journal, 2008
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Mitochondrial AKAP121 Binds and Targets Protein Tyrosine Phosphatase D1, a Novel Positive Regulator of src SignalingMolecular and Cellular Biology, 2004
- Protein-tyrosine Phosphatase D1, a Potential Regulator and Effector for Tec Family KinasesJournal of Biological Chemistry, 2000